4263 Susmed
- 605
- -1-0.17%
Susmed News
Susmed: Notice of commencement of operation of our clinical trial system utilizing blockchain technology in doctor-led clinical trials at the National Center of Neurology and Psychiatry
Susmed: (Progress of disclosure matters) Notice regarding commencement of provision of integrated venous disease registries
Susmed: Presentation of financial results for the 1st quarter of the fiscal year ending 2025/6
Susmed: Summary of financial results for the 1st quarter of the fiscal year ending June 2025 [Japanese GAAP] (unconsolidated)
Susmed: Notice Concerning Completion of Payment of New Shares as Stock Compensation with Transfer Restricted Shares
Susmed: Articles of Incorporation 2024/09/27
Susmed: Corporate Governance Report 2024/09/27
Susmed: Extraordinary Report
Susmed: Internal Control Report - 9th period (2023/07/01 - 2024/06/30)
Susmed: Financial Report - Term 9 (2023/07/01 - 2024/06/30)
Susmed: Confirmation letter
Susmed: Notice Concerning Issuance of New Shares as Stock Compensation with Transfer Restricted Shares
Susmed: Independent Officer Notification Form
Susmed: Matters relating to business plans and growth potential
Susmed: Notice of Convocation of the 9th Annual General Meeting of Shareholders and Shareholders' Meeting Materials
Susmed: Notice of approval application for partial changes in manufacturing and sales approval matters for the “SustMed Med CBT-i Insomnia Disorder App”
Susmed: Notice regarding transition to a company with an Audit and Supervisory Committee, executive personnel affairs, and partial changes to the Articles of Incorporation
Susmed: Financial results presentation materials for the period ending June 2024.
Susmed: Fiscal year ending June 2024, financial statement text (based on Japan standards) (non-consolidated)
Susmed: Announcements of individual stocks regarding the determination of the issuance of stock options (subscription rights).
No Data